Stay updated on Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial page.

Latest updates to the Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRecruitment status was updated to indicate no longer looking for participants, informing users that enrollment is closed. The page also adds new navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and makes a formatting change to the Intervention/Treatment heading, along with a revision update to v3.6.0.SummaryDifference0.5%

- Check17 days agoChange DetectedThe page shows a new Revision: v3.5.5, replacing the previous v3.5.4, indicating an updated page revision.SummaryDifference0.1%

- Check38 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4. This is a minor administrative update to the page's versioning information and does not affect the study details or how the page functions.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page revision was updated to v3.5.3, indicating a newer version of the page. This likely reflects internal updates or fixes and does not imply changes to the displayed study information.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 on the study page.SummaryDifference0.1%

- Check96 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial page.